Arghya Prosun Sarkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arghya Prosun Sarkar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bidduth Kumar Sarkar
Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh
2 shared publications - Hafez Ahmed
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh, Bangladesh
1 shared publication - Ivana Afroze
Department of Pharmacy, Faculty of Biological Sciences, Primeasia University, Dhaka-1213, Bangladesh
1 shared publication - Kamrun Nahar
Department of Pharmacy, Faculty of Biological Sciences, Primeasia University, Dhaka-1213, Bangladesh
1 shared publication - Lamia Hasan Joarder Barsha
Department of Pharmacy, Faculty of Biological Science, Islamic University, Kushtia, Bangladesh, Bangladesh
1 shared publication Maimuna Hasan
Department of Pharmacy, R P Shaha University, Narayanganj-1400, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by MDPI AG in Preprints.org
Phytochemical Profiling and Investigation of Analgesic, Anti-Diarrheal, and CNS Depressant Activity of Leea Macrophylla (Roxb.) Extract Using Experimental and Computational Approaches
Leea macrophylla is used in traditional medicine in Bangladesh, yet its whole plant has been little examined for analgesic, antidiarrheal and central nervous system (CNS) effects. A methanolic whole-plant extract (MELM) was profiled by gas chromatography–mass spectrometry (GC–MS). Male Swiss albino mice received MELM (200, 400 and 600 mg/kg) in tail-flick, formalin-induced paw-licking and biting, castor oil-induced diarrhea and phenobarbitone-induced sleep tests. Identified compounds were docked to the μ-opioid receptor, cyclooxygenase-2 (COX-2), M3 muscarinic receptor and GABA_A receptor and screened by ADMET (absorption, distribution, metabolism, excretion, toxicity) prediction. GC–MS identified 67 compounds, chiefly fatty acid derivatives and phytol. MELM increased tail-flick latency in a dose- and time-dependent manner and reduced formalin-induced licking and biting by up to 74.19% (600 mg/kg). Fecal output fell by 82.24% at 200 mg/kg, with weaker effects at higher doses. MELM shortened phenobarbitone-induced sleep, significantly at 200 and 400 mg/kg, which does not indicate CNS depression. Campesterol and lanosterol ranked among the top-scoring compounds for several targets and met all ADMET criteria. MELM shows analgesic activity in mice and these sterols warrant further experimental validation.
- 16 October 2026
- Published by MDPI AG in Preprints.org
Open AccessPhytochemical Profiling and Investigation of Analgesic, Anti-Diarrheal, and CNS Depressant Activity of Leea Macrophylla (Roxb.) Extract Using Experimental and Computational Approaches
Leea macrophylla is used in traditional medicine in Bangladesh, yet its whole plant has been little examined for analgesic, antidiarrheal and central nervous system (CNS) effects. A methanolic whole-plant extract (MELM) was profiled by gas chromatography–mass spectrometry (GC–MS). Male Swiss albino mice received MELM (200, 400 and 600 mg/kg) in tail-flick, formalin-induced paw-licking and biting, castor oil-induced diarrhea and phenobarbitone-induced sleep tests. Identified compounds were docked to the μ-opioid receptor, cyclooxygenase-2 (COX-2), M3 muscarinic receptor and GABA_A receptor and screened by ADMET (absorption, distribution, metabolism, excretion, toxicity) prediction. GC–MS identified 67 compounds, chiefly fatty acid derivatives and phytol. MELM increased tail-flick latency in a dose- and time-dependent manner and reduced formalin-induced licking and biting by up to 74.19% (600 mg/kg). Fecal output fell by 82.24% at 200 mg/kg, with weaker effects at higher doses. MELM shortened phenobarbitone-induced sleep, significantly at 200 and 400 mg/kg, which does not indicate CNS depression. Campesterol and lanosterol ranked among the top-scoring compounds for several targets and met all ADMET criteria. MELM shows analgesic activity in mice and these sterols warrant further experimental validation.
- Open Access
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 527-535
Evaluation of Antidiabetic and Antioxidant Potential of Methanolic Extract of Bixa orellana Seeds
Diabetes is considered a serious health problem in Bangladesh and worldwide. The disease is infesting all over the mother earth possessing the most damage associated with physical, mental and financial situation of the population. In this context, it’s truly essential to find an effective, safe yet economically suitable alternative medicine compared to commercially available noxious chemical drugs. Objective: This study aims to find the potential of an alternative natural extract produced from Bixa orellana seeds which is safer and more affordable comparable to the commercially available synthetic agents to reduce Hyperglycemia. It also makes effort to find the seed extracts’ ability to reduce oxidation in comparison to a standard drug, Ascorbic acid. Methodology: This is a Pharmacological study using animal model utilising rat as subjects. The rats were induced as diabetic by injecting alloxan intraperitonially and as treatment Bixa Orellana seed extracts were given to them at 500mg/kg and 1000mg/kg doses and compared with the hypogycemic effect of standard anti-diabetic drug, Metformin Hydrochloride at the dose of 100mg/kg. For analyzing the anti-oxidant activity, the DPPH free radical scavenging assay method has been used, where the IC50 values of both the Bixa Orellana seed extract and the reference drug, Ascorbic acid was collated. Results: It was found that the seed extracts used at 500 mg/kg and 1000 mg/kg evidently reduced the blood glucose level as opposed to the diabetic control group, more importantly with the rats treated with standard, Metformin Hydrochloride. Therefore, the study revealed that the seed extract can be effectively used to treat diabetic patients without any side effects. This experimentation, also by assessing the IC50 values, disclosed that the Bixa Orellana seed extract has moderate to substantial anti-oxidant potential in contrary to the reference drug.
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 527-535
Open AccessEvaluation of Antidiabetic and Antioxidant Potential of Methanolic Extract of Bixa orellana Seeds
Diabetes is considered a serious health problem in Bangladesh and worldwide. The disease is infesting all over the mother earth possessing the most damage associated with physical, mental and financial situation of the population. In this context, it’s truly essential to find an effective, safe yet economically suitable alternative medicine compared to commercially available noxious chemical drugs. Objective: This study aims to find the potential of an alternative natural extract produced from Bixa orellana seeds which is safer and more affordable comparable to the commercially available synthetic agents to reduce Hyperglycemia. It also makes effort to find the seed extracts’ ability to reduce oxidation in comparison to a standard drug, Ascorbic acid. Methodology: This is a Pharmacological study using animal model utilising rat as subjects. The rats were induced as diabetic by injecting alloxan intraperitonially and as treatment Bixa Orellana seed extracts were given to them at 500mg/kg and 1000mg/kg doses and compared with the hypogycemic effect of standard anti-diabetic drug, Metformin Hydrochloride at the dose of 100mg/kg. For analyzing the anti-oxidant activity, the DPPH free radical scavenging assay method has been used, where the IC50 values of both the Bixa Orellana seed extract and the reference drug, Ascorbic acid was collated. Results: It was found that the seed extracts used at 500 mg/kg and 1000 mg/kg evidently reduced the blood glucose level as opposed to the diabetic control group, more importantly with the rats treated with standard, Metformin Hydrochloride. Therefore, the study revealed that the seed extract can be effectively used to treat diabetic patients without any side effects. This experimentation, also by assessing the IC50 values, disclosed that the Bixa Orellana seed extract has moderate to substantial anti-oxidant potential in contrary to the reference drug.
- Open Access
- 30 September 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (3) , 1329-1341
Monkeypox Disease: An Updated Review
Monkeypox has recently garnered significant attention as a result of its rapid and simultaneous global dissemination. The objective of this study is to present a succinct overview of the existing literature, while also elucidating the development of the disease in respect to contemporary instances, possible therapeutic approaches, and strategies for preventing infection. To date, a total of 12,261 occurrences have been recorded over a wide range of 76 nations. Monkeypox is a zoonotic disease that has previously been limited to endemic areas in Western and Central Africa. However, there have been isolated outbreaks in other countries, including the United States, that have been linked to the importation of wild animals from Ghana and other affected areas. The current outbreak has seen a significant shift, with human-to-human transmission surpassing all other modes of transmission. This development has raised concerns regarding the potential extension of the outbreak within communities, particularly in cases that may have gone unreported. The observed results may be attributed to the increase in human-to-human transmission subsequent to the cessation of smallpox vaccination, which provided partial immunity against monkeypox. The occurrence of outbreaks beyond the African continent underscores the worldwide importance of the illness. The demographic that exhibits the highest vulnerability to infection is young males who engage in sexual activity with other males. While the existing understanding suggests that the clinical progression of the disease is very moderate, there remain several unresolved inquiries that necessitate additional investigation. These include the possibility of a genital reservoir of the virus in humans and the possibility of airborne transmission.
- 30 September 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (3) , 1329-1341
Open AccessMonkeypox Disease: An Updated Review
Monkeypox has recently garnered significant attention as a result of its rapid and simultaneous global dissemination. The objective of this study is to present a succinct overview of the existing literature, while also elucidating the development of the disease in respect to contemporary instances, possible therapeutic approaches, and strategies for preventing infection. To date, a total of 12,261 occurrences have been recorded over a wide range of 76 nations. Monkeypox is a zoonotic disease that has previously been limited to endemic areas in Western and Central Africa. However, there have been isolated outbreaks in other countries, including the United States, that have been linked to the importation of wild animals from Ghana and other affected areas. The current outbreak has seen a significant shift, with human-to-human transmission surpassing all other modes of transmission. This development has raised concerns regarding the potential extension of the outbreak within communities, particularly in cases that may have gone unreported. The observed results may be attributed to the increase in human-to-human transmission subsequent to the cessation of smallpox vaccination, which provided partial immunity against monkeypox. The occurrence of outbreaks beyond the African continent underscores the worldwide importance of the illness. The demographic that exhibits the highest vulnerability to infection is young males who engage in sexual activity with other males. While the existing understanding suggests that the clinical progression of the disease is very moderate, there remain several unresolved inquiries that necessitate additional investigation. These include the possibility of a genital reservoir of the virus in humans and the possibility of airborne transmission.